Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lupin Ltd.

Clinical trials sponsored by Lupin Ltd., explained in plain language.

Lupin Ltd. LUPIN NSE

Global pharmaceutical company producing generic and branded medicines.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Hope for myotonic dystrophy: new drug shows promise in easing muscle stiffness Long-Term

Symptom relief ENROLLING_BY_INVITATION

This study is testing the long-term safety and effectiveness of a drug called mexiletine PR for people with myotonic dystrophy types 1 and 2. The drug is taken once daily as a liquid to help reduce muscle stiffness (myotonia). The study includes 176 adults and teens who have alre…

Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Symptom relief

Last updated Jun 27, 2026 08:14 UTC